The ketogenic diet and cardiovascular disease prevention

Close metadata

Recommended articles:

Epilepsy with PCDH19 mutation: polypharmacy as a consequence of the complexity and diversity of pathogenesis mechanisms. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):51-55

Study of the practice of prescribing phenosanic acid in epilepsy accompanied by asthenic disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):89-97

Personality profile caused by epilepsy according to the «Big Five» model. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):16-21

Potential of specialized diet therapy in reducing toxic manifestations in patients with metastatic castration-resistant prostate cancer with bone metastases during radionuclide therapy with radium chloride [223Ra]. P.A. Herzen Journal of Oncology. 2024;(6):33-41

Brain microstructural abnormalities assessed by diffusion kurtosis MRI in patients with focal temporal lobe epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):171-177

Ototoxicity caused by anti-epileptic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):14-19

Absence status epilepticus in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):47-56

Comorbid anxiety disorders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment strategy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):126-136

Autonomic cardiovascular disorders in patients with epileptic and psychogenic non-epileptic seizures: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):13-20

A personalized approach to the diagnosis of epilepsy in obese children. Laboratory Service. 2025;(1):5-12

Diet change is the cornerstone of cardiovascular disease (CVD) prevention. While there is ongoing debate about the preferred dietary intake for CVD prevention, study results have shown a preventive effect with a variety of dietary regimens. To date, a variety of diets have been developed with different contents of proteins, fats and carbohydrates. Recently, the controversial, low-carb, high-fat ketogenic diet has been increasingly mentioned. The article discusses the ketogenic diet in the aspect of preventing the development of CVD,

Keywords:

ketogenic diet

low carbohydrate diet

high fat diet

cardiovascular disease prevention

epilepsy

nutritional care

Authors:

Sargsyan V.D.

National Medical Research Center for Therapy and Preventive Medicine

Received:

12.11.2021

Accepted:

17.11.2021

List of references:

International Diabetes Federation (2017) IDF Diabetes Atlas. UK: International Diabetes Federation; 2017. Accessed November 27, 2021. https://www.diabetesatlas.org
Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases — incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition. 2013;29:611-618.
Chiavaroli L, Viguiliouk E, Nishi SK, Blanco Mejia S, Rahelić D, Kahleová H, Salas-Salvadó J, Kendall CW, Sievenpiper JL. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients. 2019;11(2):338.
Lin JS, O’Connor EA, Evans CV, Senger CA, Rowland MG, Groom HC. Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug. Report No.: 13-05179-EF-1.
Kuller LH. Nutrition, Lipids, and Cardiovascular Disease. Nutrition Reviews. 2006;64(2):15-25.
Pahwa R, Jialal I. Atherosclerosis. Treasure Island (FL): StatPearls Publishing; 2021. Accessed May 20, 2021. https://www.ncbi.nlm.nih.gov/books/NBK507799/
Barquera S, Pedroza-Tobias A, Medina C, Hernández-Barrera L, Bibbins-Domingo K, Lozano R, Moran AE. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015;46(5):328-338.
Liese AD, Krebs-Smith SM, Subar AF, George SM, Harmon BE, Neuhouser ML, Boushey CJ, Schap TE, Reedy J. The Dietary Patterns Methods Project: synthesis of findings across cohorts and relevance to dietary guidance. J Nutr. 2015;145(3):393-402. https://doi.org/10.3945/jn.114.205336
Woodyatt R. The action of glycol aldehyde and glycerin aldehyde in diabetes mellitus and the nature of antiketogenesis. JAMA. 1910;55:2109-2112. https://doi.org/10.1001/jama.1910.04330250005003
Kossoff E, Freeman J, Turner Z, Rubenstein J. Ketogenic diets. Treatment for epilepsy and other disorders. Fifth edition. New York: Demos Medical Publishing; 2011.
Malik VS, Hu FB. Popular weight-loss diets: from evidence to practice. Nat Clin Pract Cardiovasc Med. 2007;4:34-41.
Adam-Perrot A, Clifton P, Brouns F. Low-carbohydrate diets: nutritional and physiological aspects. Obes Rev. 2006;7:49-58.
Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, Iqbal R, Kumar R, Wentzel-Viljoen E, Rosengren A, Amma LI, Avezum A, Chifamba J, Diaz R, Khatib R, Lear S, Lopez-Jaramillo P, Liu X, Gupta R, Mohammadifard N, Gao N, Oguz A, Ramli AS, Seron P, Sun Y, Szuba A, Tsolekile L, Wielgosz A, Yusuf R, Hussein Yusufali A, Teo KK, Rangarajan S, Dagenais G, Bangdiwala SI, Islam S, Anand SS, Yusuf S. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017;390(10107):2050-2062.
Seidelmann SB, Claggett B, Henglin MCS, Shah A, Steffen LM, Folsom AR, Rimm EB, Willett WC, Solomon SD. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): A prospective cohort study. Lancet. 2018;3(9):419-428.
Kossoff E, Zupec-Kania B. Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50:304-317.
Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC. A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipidemia A Randomized, Controlled Trial. Ann Intern Med. 2004;140(10): 769-777. https://doi.org/10.7326/0003-4819-140-10-200405180-00006
Hall KD, Chen KY, Guo J, Lam YY, Leibel RL, Mayer LE, Reitman ML, Rosenbaum M, Smith SR, Walsh BT, Ravussin E. Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men. Am J Clin Nutr. 2016;104(2):324-333. https://doi.org/10.3945/ajcn.116.133561
Schwarzfuchs D, Golan R, Shai I. Four-year follow-up after two-year dietary interventions. N Engl J Med. 2012;367(14):1373-1374. https://doi.org/10.1056/NEJMc1204792
Bostock ECS, Kirkby KC, Taylor BV, Hawrelak JA. Consumer Reports of «Keto Flu» Associated With the Ketogenic Diet. Front Nutr. 2020;7:20. https://doi.org/10.3389/fnut.2020.00020
de Koning L, Fung TT, Liao X, Chiuve SE, Rimm EB, Willett WC, Spiegelman D, Hu FB. Low-carbohydrate diet scores and risk of type 2 diabetes in men. Am J Clin Nutr. 2011;93(4):844-850. https://doi.org/10.3945/ajcn.110.004333
Bao W, Li S, Chavarro JE, Tobias DK, Zhu Y, Hu FB, Zhang C. Low Carbohydrate—Diet Scores and Long-term Risk of Type 2 Diabetes Among Women With a History of Gestational Diabetes Mellitus: A Prospective Cohort Study. Diabetes Care. 2016;39(1):43-49.
Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014;383: 1999-2007.
Hauner H, Bechthold A, Boeing H, Brönstrup A, Buyken A, Leschik-Bonnet E, Linseisen J, Schulze M, Strohm D, Wolfram G. Evidence-based guideline of the German Nutrition Society: carbohydrate intake and prevention of nutrition-related diseases. Ann Nutr Metab. 2012;60(suppl 1):1-58.
Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med. 2007;167(9):956-965.
Bhupathiraju SN, Tobias DK, Malik VS, Pan A, Hruby A, Manson JE, Willett WC, Hu FB. Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr. 2014;100(1):218-232. https://doi.org/10.3945/ajcn.113.079533
Kwan P, Arzimanoglou A, Berg A, Brodie M, Hauser A, Mathern G, Moshe S, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069-1077.
Likhachev S, Kulikova S, Zaitsev I, Belaja S. The theoretical justification of use of the ketogenic diet in treatment of drug-resistant epilepsy in children. Neurology and neurosurgery. Eastern Europe. 2017;7:171-183. (In Russ.).
Bough K, Gudi K, Han F, Rathod A, Eagles D. An anticonvulsant profile of the ketogenicdiet in the rat. Epilepsy Research. 2002;50:313-325.
Yudkoff M, Daikhin Y, Nissim I, Horyn O, Lazarow A, Luhovyy B, Wehrli S. Responseof brain amino acid metabolism to ketosis. Neurochemistry International. 2005;47:119-128.
Yudkoff M, Daikhin Y, Nissim I. Theketogenic diet: interactions with brain amino acidhandling. Epilepsy and the ketogenic diet. Totowa: Humana Press; 2004.
Fraser D, Whiting S, Andrew R, Macdonald E, Musa-Veloso K, Cunnane S. Elevatedpolyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology. 2003;60:1026-1029.
Vreugdenhil M, Bruehl C, Voskuyl R, Kang J, Leaf A, Wadman W. Polyunsaturated fattyacids modulate sodium and calcium currents in CA1 neurons. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:12559-12563.
Greene A, Todorova M, Seyfried T. Perspectives on the metabolic management of epilepsythrough dietary reduction of glucose and elevation of ketone bodies. Journal of Neurochemistry. 2003;86:529-537.
Hernandez-Sanchez C, Basile A, Fedorova I, Arima H, Stannard B, Fernandez A, Ito Y, LeRoith D. Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizureinduction and excitotoxic neuron death. Proceedings of the National Academy of Sciences of theUnited States of America. 2001;98:3549-3554.
Garriga-Canut M, Schoenike B, Qazi R, Bergendahl K, Daley T, Pfender R, Morrison J, Ockuly J, Stafstrom C, Sutula T, Roopra A. 2-deoxy-d-glucose reduces epilepsy progression by nrsf-ctbp-dependent metabolic regulation of chromatin structure. Nature Neuroscience. 2006;9:1382-1387.
Diano S, Matthews R, Patrylo P, Yang L, Beal M, Barnstable C, Horvath T. Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology. 2003;144:5014-5021.
Hartman A, Vining E. Clinical Aspects of the Ketogenic Diet. Epilepsia. 2007;48:31-42.

Close metadata